“Apple reinvents the phone” was the message Steve Jobs wanted his audience to take away when he introduced the iPhone. That’s ...

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced ...

Mazda used the 2025 Japan Mobility Show to look beyond 2035, unveiling two concept vehicles that represent both the company’s engineering ambitions and its evolving design philosophy.The Vision ...

Third Quarter Consolidated Revenues of $2.68 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basis over ...

Professional certifications are becoming more important for standing out in an increasingly competitive job market.

The humble Corolla nameplate has found itself attached to a few not-so-humble concepts over the last few weeks. First, we got ...

CARRUM DOWNS, VIC – October 23, 2025 – PRESSADVANTAGE – Fix-It Right Plumbing, Australia’s most trusted professional plumbing ...

Q3 2025 Earnings Call October 29, 2025 5:00 PM EDTCompany ParticipantsDarren Yip - Head of Investor RelationsWilliam McDermott ...

Good morning, and welcome to Ionis Third Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the conference over to Mr. Wade ...

Johnson & Johnson today announced plans to initiate the first head-to-head study comparing FcRn blockers for patients with generalized myasthenia gravis (gMG), which aims to affirm IMAAVYtm ...

Q3 2025 Earnings Call Transcript October 28, 2025 Incyte Corporation beats earnings expectations. Reported EPS is $2.11, ...

Late-breaking Phase III data show ianalumab, Novartis’ dual-targeted antibody, reduced disease activity and patient burden in ...